Adimab Email Format

Biotechnology ResearchNew Hampshire, United States51-200 Employees

Adimab is a mid-sized biotechnology research company based in Lebanon, New Hampshire, operating since 2007. Its core focus is antibody discovery and engineering, supported by a yeast-based platform that enables end-to-end discovery, optimization, and developability assessment. The company provides fully human antibodies and related protein modalities, including multispecifics and TCRs. It collaborates with global pharma, cutting-edge biotech, and leading academic institutions to generate therapeutic leads across a broad range of targets.

In March 2026, Adimab announced a collaboration with Gates MRI. To date, the company has conducted more than 650 discovery campaigns and developed over 90 clinical programs with more than 140 partners.

Sign up for free to view info

Company overview Employee directory